Petrova Penka
Insider CIK 1838044 · TRIL Chief Development Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 38,808 | — | $0 | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 4,574 | — | $0 | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 49,480 | — | $0 | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 83,960 | — | $0 | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 140,000 | — | $0 | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise deriv | 2021-04-08 | 2021-04-09 | 2,708 | — | $0 | 83,960 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise deriv | 2021-04-08 | 2021-04-09 | 2,604 | — | $0 | 49,480 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | S Sale | 2021-04-08 | 2021-04-09 | 5,312 | $11.09 | $58.9K | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise | 2021-04-08 | 2021-04-09 | 2,604 | $3.36 | $8.7K | 5,312 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise | 2021-04-08 | 2021-04-09 | 2,708 | $0.30 | $812 | 2,708 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise deriv | 2021-03-10 | 2021-03-12 | 2,604 | — | $0 | 52,084 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise deriv | 2021-03-10 | 2021-03-12 | 2,708 | — | $0 | 86,668 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | S Sale | 2021-03-10 | 2021-03-12 | 5,312 | $11.08 | $58.9K | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise | 2021-03-10 | 2021-03-12 | 2,604 | $3.35 | $8.7K | 5,312 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise | 2021-03-10 | 2021-03-12 | 2,708 | $0.30 | $812 | 2,708 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise deriv | 2021-02-09 | 2021-02-10 | 508 | — | $0 | 4,574 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | S Sale | 2021-02-09 | 2021-02-10 | 508 | $14.17 | $7.2K | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise | 2021-02-09 | 2021-02-10 | 508 | $9.62 | $4.9K | 508 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise deriv | 2021-02-08 | 2021-02-10 | 2,708 | — | $0 | 89,376 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise deriv | 2021-02-08 | 2021-02-10 | 2,604 | — | $0 | 54,688 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise | 2021-02-08 | 2021-02-10 | 2,708 | $0.30 | $812 | 2,708 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise | 2021-02-08 | 2021-02-10 | 2,604 | $3.31 | $8.6K | 5,312 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | S Sale | 2021-02-08 | 2021-02-10 | 5,312 | $12.65 | $67.2K | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise deriv | 2021-01-11 | 2021-01-13 | 508 | — | $0 | 5,082 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | S Sale | 2021-01-11 | 2021-01-13 | 508 | $15.21 | $7.7K | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise | 2021-01-11 | 2021-01-13 | 508 | $9.57 | $4.9K | 508 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise deriv | 2021-01-08 | 2021-01-12 | 2,604 | — | $0 | 57,292 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise | 2021-01-08 | 2021-01-12 | 2,604 | $3.33 | $8.7K | 2,604 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | S Sale | 2021-01-08 | 2021-01-12 | 2,604 | $15.50 | $40.4K | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise deriv | 2021-01-07 | 2021-01-11 | 2,708 | — | $0 | 92,084 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | S Sale | 2021-01-07 | 2021-01-11 | 2,708 | $14.71 | $39.8K | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise | 2021-01-07 | 2021-01-11 | 2,708 | $0.30 | $812 | 2,708 | SEC↗ |